137 related articles for article (PubMed ID: 37149089)
21. Strong OLIG2 expression in supratentorial ependymoma, ZFTA fusion-positive: A potential diagnostic pitfall.
de Castro JVA; Kulikowski LD; Wolff BM; Natalino R; Carraro DM; Torrezan GT; Scapulatempo Neto C; Amancio CT; Canedo FSNA; Feher O; Costa FD
Neuropathology; 2024 Apr; 44(2):167-172. PubMed ID: 37855183
[TBL] [Abstract][Full Text] [Related]
22. A non-hemispheric transtentorial ZFTA fusion-positive ependymoma in a 6-month-old boy.
Cardoni A; Barresi S; Piccirilli E; Alesi V; Miele E; Giovannoni I; Genovese S; Del Baldo G; Diomedi-Camassei F; Antonelli M; Giangaspero F; Puggioni C; Carai A; Colafati GS; Mastronuzzi A; Gessi M; Alaggio R; Rossi S
Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12886. PubMed ID: 36709981
[No Abstract] [Full Text] [Related]
23. Ependymoma-like tumor with mesenchymal differentiation (ELTMD) with ZFTA:NCOA1 fusion: A diagnostic challenge.
Dorwal P; White C; Goh AF; Kumar A; McEniery J; Walker R; Robertson T
Neuropathology; 2024 Jun; 44(3):216-221. PubMed ID: 37931917
[TBL] [Abstract][Full Text] [Related]
24. [Precision Medicine for Ependymoma].
Gomi A
No Shinkei Geka; 2022 Jan; 50(1):91-100. PubMed ID: 35169089
[TBL] [Abstract][Full Text] [Related]
25. Supratentorial extra-axial RELA fusion-positive ependymoma misdiagnosed as meningioma by intraoperative histological and cytological examinations: a case report.
Nagayasu MA; Fukushima T; Matsumoto F; Takeshima H; Sato Y; Kataoka H
J Med Case Rep; 2022 Aug; 16(1):312. PubMed ID: 35986385
[TBL] [Abstract][Full Text] [Related]
26. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
Fukuoka K; Kanemura Y; Shofuda T; Fukushima S; Yamashita S; Narushima D; Kato M; Honda-Kitahara M; Ichikawa H; Kohno T; Sasaki A; Hirato J; Hirose T; Komori T; Satomi K; Yoshida A; Yamasaki K; Nakano Y; Takada A; Nakamura T; Takami H; Matsushita Y; Suzuki T; Nakamura H; Makino K; Sonoda Y; Saito R; Tominaga T; Matsusaka Y; Kobayashi K; Nagane M; Furuta T; Nakada M; Narita Y; Hirose Y; Ohba S; Wada A; Shimizu K; Kurozumi K; Date I; Fukai J; Miyairi Y; Kagawa N; Kawamura A; Yoshida M; Nishida N; Wataya T; Yamaoka M; Tsuyuguchi N; Uda T; Takahashi M; Nakano Y; Akai T; Izumoto S; Nonaka M; Yoshifuji K; Kodama Y; Mano M; Ozawa T; Ramaswamy V; Taylor MD; Ushijima T; Shibui S; Yamasaki M; Arai H; Sakamoto H; Nishikawa R; Ichimura K;
Acta Neuropathol Commun; 2018 Dec; 6(1):134. PubMed ID: 30514397
[TBL] [Abstract][Full Text] [Related]
27. Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology.
Gessi M; Giagnacovo M; Modena P; Elefante G; Gianno F; Buttarelli FR; Arcella A; Donofrio V; Diomedi Camassei F; Nozza P; Morra I; Massimino M; Pollo B; Giangaspero F; Antonelli M
Am J Surg Pathol; 2019 Jan; 43(1):56-63. PubMed ID: 29266023
[TBL] [Abstract][Full Text] [Related]
28. C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation.
Ozawa T; Kaneko S; Szulzewsky F; Qiao Z; Takadera M; Narita Y; Kondo T; Holland EC; Hamamoto R; Ichimura K
Acta Neuropathol Commun; 2021 Mar; 9(1):36. PubMed ID: 33685520
[TBL] [Abstract][Full Text] [Related]
29. C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.
Cachia D; Wani K; Penas-Prado M; Olar A; McCutcheon IE; Benjamin RS; Armstrong TS; Gilbert MR; Aldape KD
Brain Tumor Pathol; 2015 Apr; 32(2):105-11. PubMed ID: 25388523
[TBL] [Abstract][Full Text] [Related]
30. Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma.
Tomomasa R; Arai Y; Kawabata-Iwakawa R; Fukuoka K; Nakano Y; Hama N; Nakata S; Suzuki N; Ishi Y; Tanaka S; Takahashi JA; Yuba Y; Shiota M; Natsume A; Kurimoto M; Shiba Y; Aoki M; Nabeshima K; Enomoto T; Inoue T; Fujimura J; Kondo A; Yao T; Okura N; Hirose T; Sasaki A; Nishiyama M; Ichimura K; Shibata T; Hirato J; Yokoo H; Nobusawa S
Brain Pathol; 2021 May; 31(3):e12943. PubMed ID: 33576087
[TBL] [Abstract][Full Text] [Related]
31. C11orf95-RELA fusion present in a primary intracranial extra-axial ependymoma: Report of a case with literature review.
Nambirajan A; Malgulwar PB; Sharma MC; Singh A; Pathak P; Satyarthee GD; Garg A
Neuropathology; 2016 Oct; 36(5):490-495. PubMed ID: 27121356
[TBL] [Abstract][Full Text] [Related]
32. Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features.
Tamai S; Nakano Y; Kinoshita M; Sabit H; Nobusawa S; Arai Y; Hama N; Totoki Y; Shibata T; Ichimura K; Nakada M
Brain Tumor Pathol; 2021 Jan; 38(1):64-70. PubMed ID: 33221956
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic characterization with somatic genome editing and gene transfer reveals the diverse oncogenicity of ependymoma fusion genes.
Takadera M; Satomi K; Szulzewsky F; Cimino PJ; Holland EC; Yamamoto T; Ichimura K; Ozawa T
Acta Neuropathol Commun; 2020 Nov; 8(1):203. PubMed ID: 33228790
[TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance imaging findings of intracranial extraventricular ependymoma: A retrospective multi-center cohort study of 114 cases.
Li L; Fu Y; Zhang Y; Mao Y; Huang D; Yi X; Wang J; Tan Z; Jiang M; Chen BT
Cancer Med; 2023 Aug; 12(15):16195-16206. PubMed ID: 37376821
[TBL] [Abstract][Full Text] [Related]
35. C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin.
Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Rajeshwari M; Singh M; Suri V; Sarkar C; Sharma MC
J Neurooncol; 2018 May; 138(1):29-39. PubMed ID: 29354850
[TBL] [Abstract][Full Text] [Related]
36. RELA Fusion-Positive Ependymoma in a Child with Down Syndrome: A Case Report.
Chan JL; Kashanian A; Bannykh SI; Majlessipour F; Breunig JJ; Danielpour M
Pediatr Neurosurg; 2021; 56(2):146-151. PubMed ID: 33690230
[TBL] [Abstract][Full Text] [Related]
37. Characterization of molecular signatures of supratentorial ependymomas.
Torre M; Alexandrescu S; Dubuc AM; Ligon AH; Hornick JL; Meredith DM
Mod Pathol; 2020 Jan; 33(1):47-56. PubMed ID: 31375768
[TBL] [Abstract][Full Text] [Related]
38. A novel type of C11orf95-LOC-RELA fusion in a grade II supratentorial ependymoma: report of a case with literature review.
de Sousa GR; Marie SKN; Oba-Shinjo SM; Ramalho LNZ; Tone LG; Valera ET
Childs Nerv Syst; 2019 Apr; 35(4):689-694. PubMed ID: 30631904
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Conventional, Diffusion, and Perfusion MRI Between Low-Grade and Anaplastic Extraventricular Ependymoma.
Xing Z; Zhou X; Xiao Z; She D; Wang X; Cao D
AJR Am J Roentgenol; 2020 Oct; 215(4):978-984. PubMed ID: 32809860
[No Abstract] [Full Text] [Related]
40. Pediatric Supratentorial Ependymoma: Surgical, Clinical, and Molecular Analysis.
Lillard JC; Venable GT; Khan NR; Tatevossian RG; Dalton J; Vaughn BN; Klimo P
Neurosurgery; 2019 Jul; 85(1):41-49. PubMed ID: 29917116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
